John C. Herr, PhD, Professor of Cell Biology, Center Director, Department of Cell Biology, University of Virginia Health System, discusses sperm protein 10 (SP-10), which is used to…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses Tulane’s Breast Cancer Center. References and…
Francis G. Spinale, MD, PhD, Associate Professor, Department of Surgery, Medical University of South Carolina, discusses biomarkers in heart failure. References and Resources Spinale FG. Myocardial matrix remodeling…
Using a multivariate regression analysis, it has been shown that people with a common genetic mutation have up to twice the risk of lung cancer as do people…
A recent study shows that malignant high-grade PINs have a greater expression of PTOV1 (prostate tumor overexpressed-1) compared with benign lesions, and as expression of PTOV1 decreased, so…
Saul E. Rivkin, MD, Founder of the Marsha Rivkin Center for Ovarian Cancer, Medical Oncologist, Swedish Cancer Institute, Seattle, WA, discusses the future of testing for early stage…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, discusses the possibility of the use of sputum analysis for lung cancer screening. References…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, shares his thoughts on the cost of lung cancer screening. Sponsored by The Doctor’s…
According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his thoughts on…
